

Is Paxlovid 150 Mg /100 Mg Dose Pack in shortage in 2026? Get the latest update on availability, cost, and what to do if you can't find it.
If you've been prescribed Paxlovid 150 Mg /100 Mg Dose Pack and had trouble finding it at your pharmacy, you might be wondering: is Paxlovid in shortage? The short answer is no — Paxlovid is not on the FDA's official drug shortage list as of early 2026. But that doesn't mean it's always easy to find, especially the renal dose pack.
In this article, we'll break down the current availability picture, explain why you might still have trouble getting your prescription filled, and share what you can do about it.
Paxlovid is not currently listed on the FDA or ASHP drug shortage databases. Pfizer has maintained a steady commercial supply since the drug received full FDA approval in May 2023 and completed the transition from government-distributed EUA stock in early 2024.
However, "not in shortage" doesn't mean "always on the shelf." During COVID-19 surges — particularly in fall and winter — pharmacies can run through their Paxlovid inventory quickly. The 150 Mg /100 Mg Dose Pack (the renal dose) is especially vulnerable because pharmacies stock far fewer units of it compared to the standard dose pack.
Several factors can make Paxlovid 150 Mg /100 Mg Dose Pack difficult to locate:
COVID-19 continues to circulate seasonally. During winter waves, prescriptions for Paxlovid increase dramatically. Pharmacies that normally keep one or two renal dose packs on hand may sell out within hours.
The 150 Mg /100 Mg Dose Pack serves a smaller patient population — those with moderate kidney impairment. Because demand is lower year-round, pharmacies keep minimal inventory. This creates a bottleneck when multiple patients need the renal dose at the same time.
At $1,400 to $1,800 per 5-day course, Paxlovid is an expensive medication for pharmacies to keep on the shelf. Some smaller pharmacies limit how many dose packs they stock to manage their inventory costs, particularly for the less-requested renal formulation.
The cash price for a 5-day course of Paxlovid remains in the $1,400 to $1,800 range without insurance. Here's what you can expect depending on your coverage:
For detailed information on saving money, read our guide to Paxlovid coupons, discounts, and patient assistance.
The COVID-19 treatment landscape continues to evolve. As of 2026, the main options for high-risk patients remain:
Researchers continue to develop new antivirals and treatments, but for now these three remain the primary options. If your doctor has prescribed Paxlovid, it's because it is the most effective oral treatment currently available.
Learn more about your options in our guide to Paxlovid alternatives.
If your pharmacy is out of stock, here are the best steps to take:
For a detailed walkthrough, see our complete guide to finding Paxlovid in stock.
Paxlovid 150 Mg /100 Mg Dose Pack is not in a formal shortage in 2026, but real-world availability can be spotty — especially during COVID surges and for the renal dose formulation. The high cost and limited pharmacy stocking make it harder to find than many other medications.
If you've been prescribed Paxlovid, act fast. Use Medfinder to locate it, explore financial assistance through the PAXCESS program, and talk to your doctor about alternatives if you truly can't find it. Time is critical — starting treatment early gives you the best chance of avoiding severe illness.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.